In This Article:
- By insider
Chairman, President & CEO of Merck & Co Inc (MRK) Kenneth C Frazier sold 279,850 shares of MRK on 10/02/2018 at an average price of $72.07 a share. The total sale was $20.2 million.
Merck & Co Inc is a health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. Merck & Co Inc has a market cap of $189.81 billion; its shares were traded at around $71.37 with a P/E ratio of 142.74 and P/S ratio of 4.69. The dividend yield of Merck & Co Inc stocks is 2.69%.
-
Warning! GuruFocus has detected 7 Warning Signs with MRK. Click here to check it out.
-
The intrinsic value of MRK
CEO Recent Trades:
-
Chairman, President & CEO Kenneth C Frazier sold 279,850 shares of MRK stock on 10/02/2018 at the average price of $72.07. The price of the stock has decreased by 0.97% since.
-
Chairman, President & CEO Kenneth C Frazier sold 279,851 shares of MRK stock on 09/18/2018 at the average price of $70.08. The price of the stock has increased by 1.84% since.
Directors and Officers Recent Trades:
-
EVP & Pres-Global Human Health Adam H Schechter sold 107,360 shares of MRK stock on 09/17/2018 at the average price of $70.18. The price of the stock has increased by 1.7% since.
For the complete insider trading history of MRK, click here
.This article first appeared on GuruFocus.
-
Warning! GuruFocus has detected 7 Warning Signs with MRK. Click here to check it out.
-
The intrinsic value of MRK